Schrödinger, Inc. (SDGR) News
Follow Schrödinger, Inc. (SDGR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 8 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
SDGR: AI-driven platform innovation and hosted solutions fuel growth, with profitability targeted by 2028
The conference highlighted advances in computational drug discovery, integration of AI, and the launch of Bunsen to automate workflows. Strong customer adoption, new product rollouts, and a shift to hosted solutions are
NEWS | Sep 14, 2026, 07:19 PM UTC
L
SDGR: Strong growth, platform innovation, and new products drive momentum and profitability focus
The conference highlighted advances in computational drug discovery, with strong growth in software and hosted solutions, new product launches like Bunsen and Predictive Tox, and expanding partnerships. Financial perform
NEWS | Sep 14, 2026, 06:52 PM UTC
L
Schrödinger co-founds Tectora with NEA, RA Capital and closes $55M
Schrödinger (SDGR) announced the formation of Tectora, a biotechnology company focused on immunology and inflammation. Tectora co-founded by Schrödinger with NEA and RA Capital Management; Tectora concurrently closed a $
EQUITY | Sep 09, 2026, 11:00 AM UTC
L
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
AUSTIN, Texas, Sept. 3, 2026 // -- Equity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it. Arizton values the global AI in drug dis
EQUITY | Sep 03, 2026, 12:55 PM UTC
L
Schrödinger to take part in Morgan Stanley Global Healthcare conference chat
Schrödinger (SDGR) announced management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, Sept. 14, 2026 at 1:05 p.m. ET, with a live webcast available.
EQUITY | Sep 01, 2026, 12:30 PM UTC
L
SDGR Posts Q2 Net Income $6.0m
SDGR reports Q2 net income and revenue
EARNINGS | Aug 05, 2026, 08:18 PM UTC
L
Private Markets: Chai Discovery, Etched land major rounds
Chai Discovery and Etched secured hundreds of millions in new financing, pushing valuations into multibillion dollar territory and drawing comparisons to publicly traded leaders in their sectors. This week's private comp
EQUITY | Jul 23, 2026, 06:52 PM UTC
H
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI
While corporate America is becoming more selective about using artificial intelligence as a rationale for acquisitions, Anthropic is making its biggest bet yet that AI will reshape scientific research. The AI startup on
MNA | Jul 01, 2026, 11:50 AM UTC